Maravai LifeSciences Holdings
Stock Forecast, Prediction & Price Target
Maravai LifeSciences Holdings Financial Estimates
Maravai LifeSciences Holdings Revenue Estimates
Maravai LifeSciences Holdings EBITDA Estimates
Maravai LifeSciences Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $799.24M N/A | $883.00M 10.48% | $288.94M -67.27% | Avg: $303.23M Low: $295.27M High: $313.84M avg. 4.94% | Avg: $350.32M Low: $340.92M High: $365.38M avg. 15.53% | Avg: $971.72M Low: $945.64M High: $1.01B avg. 177.37% | Avg: $1.31B Low: $1.28B High: $1.37B avg. 35.41% |
Net Income
% change YoY
| $469.25M N/A | $490.66M 4.56% | $-119.02M -124.25% | Avg: $-7.36M Low: $-51.44M High: $7.91M avg. 93.80% | Avg: $-16.7M Low: $-15.83M High: $-1.31M avg. -126.62% | Avg: $27.70M Low: $26.73M High: $29.25M avg. 265.88% | Avg: $48.81M Low: $47.10M High: $51.53M avg. 76.19% |
EBITDA
% change YoY
| $543.67M N/A | $568.39M 4.54% | $712.40M 25.33% | Avg: $130.14M Low: $126.73M High: $134.70M avg. -81.73% | Avg: $150.36M Low: $146.32M High: $156.82M avg. 15.53% | Avg: $417.07M Low: $405.87M High: $435.00M avg. 177.37% | Avg: $564.79M Low: $549.64M High: $589.07M avg. 35.41% |
EPS
% change YoY
| $4.09 N/A | $3.73 -8.80% | -$0.9 -124.12% | Avg: -$0.11 Low: -$0.39 High: $0.06 avg. 88.22% | Avg: -$0.07 Low: -$0.12 High: -$0.01 avg. 38.67% | Avg: $0.21 Low: $0.2 High: $0.22 avg. 423.07% | Avg: $0.37 Low: $0.36 High: $0.39 avg. 76.19% |
Operating Expenses
% change YoY
| $115.28M N/A | $147.62M 28.05% | $171.85M 16.40% | Avg: $83.21M Low: $81.02M High: $86.12M avg. -51.57% | Avg: $96.13M Low: $93.55M High: $100.26M avg. 15.53% | Avg: $266.65M Low: $259.49M High: $278.11M avg. 177.37% | Avg: $361.10M Low: $351.41M High: $376.62M avg. 35.41% |
FAQ
What is Maravai LifeSciences Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 77.31% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -51.44M, average is -7.36M and high is 7.91M.
What is Maravai LifeSciences Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 58.31% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $295.27M, average is $303.23M and high is $313.84M.
What is Maravai LifeSciences Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 156.54% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$0.39, average is -$0.11 and high is $0.06.
What is the best performing analyst?
In the last twelve months analysts have been covering Maravai LifeSciences Holdings stock. The most successful analyst is Catherine Schulte.